HOLLISTON, Mass., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (HBIO) today announced that it will be showcasing its latest product innovations at the Society for Neuroscience (SfN) ...
Harvard Bioscience said that once fully implemented, the move will provide about $4 million in annual cost savings.
Amid NIH funding delays, reversals and uncertainty, a scientist at Harvard who studies breast cancer has lost one-third of ...
Streamlining production footprint and improving manufacturing efficiency through phased closure of Holliston, MA plant Initiative expected to ...
The MarketWatch News Department was not involved in the creation of this content. HOLLISTON, Mass., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the "Company" or ...
F. Hoffmann-La Roche, one of the world’s largest biotechnology companies, announced last week that it would more than triple ...
Harvard Bioscience makes laboratory instruments and devices that support research in areas like drug discovery, therapy development, and preclinical testing. Its core products are used by universities ...
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. It operates ...
HOLLISTON, Mass. (AP) — HOLLISTON, Mass. (AP) — Harvard Bioscience Inc. (HBIO) on Monday reported a loss of $2.3 million in its second quarter. The Holliston, Massachusetts-based company said it had a ...
HOLLISTON, Mass. (AP) — HOLLISTON, Mass. (AP) — Harvard Bioscience Inc. (HBIO) on Thursday reported a loss of $1.2 million in its third quarter. The Holliston, Massachusetts-based company said it had ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results